Observation of the Efficacy and Tolerance of Motens® (Lacidipine) in Patients With Essential Hypertension
NCT02235415 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24526
Last updated 2014-09-10
Summary
Study of the efficacy and tolerance of Motens® (lacidipine) in patients with essential hypertension. To obtain information on the dosage used in practice and the tolerance at the start of treatment (12 weeks)
Conditions
Interventions
- DRUG
-
Motens® (lacidipine)
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1998-06-30
- Primary Completion
- 1999-09-30
More Related Trials
-
Safety and Efficacy Study of LHW090 in Resistant Hypertension Patients
NCT02515331 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension
NCT00765947 ·Status: COMPLETED ·Phase: PHASE4
-
Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension
NCT02184858 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients
NCT01042392 ·Status: COMPLETED ·Phase: PHASE4
-
A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety
NCT03541174 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Aliskiren and Atenolol in Adults (>18) With Mild to Moderate Hypertension
NCT00262236 ·Status: COMPLETED ·Phase: PHASE3
-
Determining the Optimal Dose of AD-209 in Patients With Essential Hypertension
NCT04218552 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.
NCT00219024 ·Status: COMPLETED ·Phase: PHASE3
-
A Dose Finding Study Of PF-00489791 In Patients With Mild To Moderate High Blood Pressure
NCT00422461 ·Status: COMPLETED ·Phase: PHASE2
-
A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren in Patients With High Blood Pressure
NCT00260923 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine
NCT00294710 ·Status: COMPLETED ·Phase: PHASE3
-
Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals
NCT02238262 ·Status: COMPLETED
-
Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension
NCT01122251 ·Status: COMPLETED ·Phase: PHASE2
-
Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension
NCT00942994 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Atacand® (Candesartan) in Daily Medical Practice
NCT00837720 ·Status: COMPLETED
-
A Clinical Study to Compare the Safety and Efficacy of an Aliskiren-based Regimen With a Lisinopril Based Regimen in Patients With Severe Hypertension
NCT00219050 ·Status: COMPLETED ·Phase: PHASE3
-
Real Life Experience of the Use of Isomers as ALENCAL (Levamlodipine) for Evaluation of Efficacy, Safety and Tolerability in the Management of Cardiovascular Disease in Colombian Patients
NCT01429233 ·Status: UNKNOWN
-
A Clinical Study to Compare Combination of Aliskiren+ HCTZ to Irbesartan+ HCTZ or Amlodipine+ HCTZ or HCTZ Alone in Obese Hypertensive Not Responsive to HCTZ 25 mg
NCT00219115 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients
NCT01928628 ·Status: COMPLETED ·Phase: PHASE3
-
Tolerance to Target Doses of Thiazides in Actual Practice: A Feasibility Study
NCT01235377 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal.
NCT00219063 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension
NCT01237223 ·Status: COMPLETED ·Phase: PHASE3
-
A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)
NCT00246584 ·Status: COMPLETED ·Phase: PHASE2
-
A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren 150mg, 300mg, and 600mg to Placebo in Patients With High Blood Pressure.
NCT00219128 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6-17 Years of Age
NCT00834041 ·Status: COMPLETED ·Phase: PHASE1/PHASE2